NASDAQ:APRE | Insider Transactions — Page 2 | Aprea Therapeutics, Inc.

APRE Insider Transactions — Page 2

151 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–151; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
PARMAR KUSHTenPercentOwner2020-05-19Sale10,200.0$35.15
5AM Opportunities I, L.P.TenPercentOwner2020-05-19Sale10,200.0$35.15
5AM Opportunities I (GP), LLCTenPercentOwner2020-05-19Sale10,200.0$35.15
DIEKMAN JOHN DTenPercentOwner2020-05-19Sale244,800.0$35.15
5AM Partners IV, LLCTenPercentOwner2020-05-19Sale244,800.0$35.15
5AM Ventures IV, L.P.TenPercentOwner2020-05-19Sale244,800.0$35.15
5AM Co-Investors IV, L.P.TenPercentOwner2020-05-19Sale244,800.0$35.15
Schwab Andrew J.TenPercentOwner2020-05-19Sale244,800.0$35.15
PARMAR KUSHTenPercentOwner2020-05-19Sale244,800.0$35.15
5AM Opportunities I, L.P.TenPercentOwner2020-05-19Sale244,800.0$35.15
5AM Opportunities I (GP), LLCTenPercentOwner2020-05-19Sale244,800.0$35.15
KDev Investments ABTenPercentOwner2020-04-13Sale210,548.0$31.25
Karolinska Development ABTenPercentOwner2020-04-13Sale210,548.0$31.25
KCIF Co-Investment Fund KBTenPercentOwner2020-04-13Sale210,548.0$31.25
DIEKMAN JOHN DTenPercentOwner2019-10-07Purchase333,333.0$15.0
5AM Partners IV, LLCTenPercentOwner2019-10-07Purchase333,333.0$15.0
5AM Ventures IV, L.P.TenPercentOwner2019-10-07Purchase333,333.0$15.0
5AM Co-Investors IV, L.P.TenPercentOwner2019-10-07Purchase333,333.0$15.0
Schwab Andrew J.TenPercentOwner2019-10-07Purchase333,333.0$15.0
PARMAR KUSHTenPercentOwner2019-10-07Purchase333,333.0$15.0
5AM Opportunities I, L.P.TenPercentOwner2019-10-07Purchase333,333.0$15.0
5AM Opportunities I (GP), LLCTenPercentOwner2019-10-07Purchase333,333.0$15.0
Redmile Group, LLCTenPercentOwner2019-10-07Purchase400,000.0$15.0
Green JeremyTenPercentOwner2019-10-07Purchase400,000.0$15.0
Versant Vantage I, L.P.TenPercentOwner2019-10-07Purchase333,333.0$15.0
Versant Vantage I GP, L.P.TenPercentOwner2019-10-07Purchase333,333.0$15.0
Versant Vantage I GP-GP, LLCTenPercentOwner2019-10-07Purchase333,333.0$15.0
Versant Affiliates Fund V, L.P.TenPercentOwner2019-10-07Purchase333,333.0$15.0
Versant Venture Capital V, L.P.TenPercentOwner2019-10-07Purchase333,333.0$15.0
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2019-10-07Purchase333,333.0$15.0
Versant Venture Capital V (Canada), LPTenPercentOwner2019-10-07Purchase333,333.0$15.0
Versant Ventures V GP-GP (Canada), Inc.TenPercentOwner2019-10-07Purchase333,333.0$15.0
Versant Ventures V, LLCTenPercentOwner2019-10-07Purchase333,333.0$15.0
Versant Ventures V (Canada), L.P.TenPercentOwner2019-10-07Purchase333,333.0$15.0
Versant V Luxco S.a r.l.TenPercentOwner2019-10-07Purchase333,333.0$15.0
Christenson JohanDirector2019-10-07Purchase266,667.0$15.0
Magni GuidoDirector2019-10-07Purchase6,500.0$15.0
HENNEMAN JOHN B IIIDirector2019-10-07Purchase5,000.0$15.0
Korbel Gregory AlanVP of Business Dev't2019-10-07Purchase500.0$15.0
Attar Eyal C.SVP, Chief Medical Officer2019-10-07Purchase200.0$15.0
Attar Eyal C.SVP, Chief Medical Officer2019-10-07Purchase200.0$15.0
Coiante Scott MSVP, Chief Financial Officer2019-10-07Purchase2,500.0$15.0
SCHADE CHRISTIAN SPresident & CEO2019-10-07Purchase5,000.0$15.0
SCHADE CHRISTIAN SPresident & CEO2019-10-07Purchase1,000.0$15.0
SCHADE CHRISTIAN SPresident & CEO2019-10-07Purchase1,000.0$15.0
SCHADE CHRISTIAN SPresident & CEO2019-10-07Purchase1,000.0$15.0
SCHADE CHRISTIAN SPresident & CEO2019-10-07Purchase1,000.0$15.0
SCHADE CHRISTIAN SPresident & CEO2019-10-07Purchase1,000.0$15.0
SCHADE CHRISTIAN SPresident & CEO2019-10-07Purchase1,000.0$15.0
HealthCap VII, L.P.TenPercentOwner2019-10-07Purchase266,667.0$15.0
HealthCap VII GP S.A.TenPercentOwner2019-10-07Purchase266,667.0$15.0